Friday, July 10, 2026

Drug profile · INN

ioflupane (123i)

ioflupane (123i) (CELSUNAX) is a diagnostic agent.

EMA: approved Various (V09) V09AB03
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — ioflupane (123i)
Class
Various (V09)
Route
Patents
0
Programs
5
Data quality
0.83

Quick answer

ioflupane (123i) (CELSUNAX) is a diagnostic agent.

Key facts

INN ioflupane (123i)
Brand CELSUNAX
Mechanism Diagnostic agent
Therapeutic class Various (V09)
ATC code V09AB03

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. IOBENGUANE (123I) , 68Ga-SSO120 Phase 2 · AXIM Biotechnologies · neuroblastoma
  2. PS22PET Phase 2 · AXIM Biotechnologies · (suspision on) Neuroblastoma
  3. [123I] 5-IA Phase 2 · United Therapeutics Europe · Parkinson Disease
  4. [123I] IBVM and SPECT imaging Phase 1 · United Therapeutics Europe · Parkinson Disease
  5. Radio-Flu 0 for Transthyretin amyloid cardiomyopathy Approved · Disc Medicine · Transthyretin amyloid cardiomyopathy

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is ioflupane (123i)?

ioflupane (123i) (CELSUNAX) is a diagnostic agent.

What is the brand name for ioflupane (123i)?

CELSUNAX is a marketed brand name for ioflupane (123i). Check FDA Drugs@FDA for the current US label holder and prescribing information.